Unlike the other weight loss injections, that are GLP-1 receptor agonists, it has a powerful double action, being a GLP-1 and GIP receptor agonist." Dorianne Green, Medical Writer Clinical studies highlight impressive results: average weight losses of 15% at 5 mg, 19% at 10 mg, and 21% at 15 mg
The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging (Metabolism: Clinical and Experimental)
P., & Cobiac, L
Mann et al., 2017), and non-steroidal mineralocorticoid receptor antagonists (ns-MRAs) such as finerenone (Scholtes et al., 2022
[DOI] [PubMed] [Google Scholar] Kabir M.T., Uddin M.S., Jeandet P., Emran T.B., Mitra S., Albadrani G.M., Sayed A.A., Abdel-Daim M.M., Simal-Gandara J
At 8mg, that figure was approximately 71%